227 related articles for article (PubMed ID: 21765467)
21. Macrophage alternative activation confers protection against lipotoxicity-induced cell death.
Dai L; Bhargava P; Stanya KJ; Alexander RK; Liou YH; Jacobi D; Knudsen NH; Hyde A; Gangl MR; Liu S; Lee CH
Mol Metab; 2017 Oct; 6(10):1186-1197. PubMed ID: 29031719
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
23. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
Han EJ; Im CN; Park SH; Moon EY; Hong SH
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
[TBL] [Abstract][Full Text] [Related]
24. PPARδ signaling regulates colorectal cancer.
You M; Yuan S; Shi J; Hou Y
Curr Pharm Des; 2015; 21(21):2956-9. PubMed ID: 26004416
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Takada I; Makishima M
Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
[No Abstract] [Full Text] [Related]
26. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
Yang YC; Tsao YP; Ho TC; Choung IP
Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
[TBL] [Abstract][Full Text] [Related]
27. Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.
Chen Y; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y; Qian J
Diab Vasc Dis Res; 2017 Mar; 14(2):152-162. PubMed ID: 28111985
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells.
Chang HK; Kim DS; Chae JJ; Kim M; Myong JP; Lee KH; Lee MW; Park TC
Biochem Biophys Res Commun; 2017 Jan; 482(4):843-848. PubMed ID: 27888104
[TBL] [Abstract][Full Text] [Related]
29. Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression.
Wang D; Wang H; Guo Y; Ning W; Katkuri S; Wahli W; Desvergne B; Dey SK; DuBois RN
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19069-74. PubMed ID: 17148604
[TBL] [Abstract][Full Text] [Related]
30. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.
Hummasti S; Tontonoz P
Mol Endocrinol; 2006 Jun; 20(6):1261-75. PubMed ID: 16556736
[TBL] [Abstract][Full Text] [Related]
31. The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells.
Wang Y; Tan H; Xu D; Ma A; Zhang L; Sun J; Yang Z; Liu Y; Shi G
Int J Mol Med; 2014 Jul; 34(1):262-8. PubMed ID: 24820432
[TBL] [Abstract][Full Text] [Related]
32. Aspirin-induced apoptosis in jurkat cells is not mediated by peroxisome proliferator-activated receptor delta.
López JM; Fernández MA; Piqué M; Gil J
Mol Cell Biochem; 2004 Nov; 266(1-2):57-63. PubMed ID: 15646027
[TBL] [Abstract][Full Text] [Related]
33. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
Evans JL; Lin JJ; Goldfine ID
Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
[TBL] [Abstract][Full Text] [Related]
34. An L-tyrosine derivative and PPARgamma agonist, GW7845, activates a multifaceted caspase cascade in bone marrow B cells.
Schlezinger JJ; Emberley JK; Bissonnette SL; Sherr DH
Toxicol Sci; 2007 Jul; 98(1):125-36. PubMed ID: 17400580
[TBL] [Abstract][Full Text] [Related]
35. Ligand-Activated Peroxisome Proliferator-Activated Receptor δ Attenuates Vascular Oxidative Stress by Inhibiting Thrombospondin-1 Expression.
Ahn MY; Ham SA; Yoo T; Lee WJ; Hwang JS; Paek KS; Lim DS; Han SG; Lee CH; Seo HG
J Vasc Res; 2018; 55(2):75-86. PubMed ID: 29408825
[TBL] [Abstract][Full Text] [Related]
36. Identification of a PPARdelta agonist with partial agonistic activity on PPARgamma.
Connors RV; Wang Z; Harrison M; Zhang A; Wanska M; Hiscock S; Fox B; Dore M; Labelle M; Sudom A; Johnstone S; Liu J; Walker NP; Chai A; Siegler K; Li Y; Coward P
Bioorg Med Chem Lett; 2009 Jul; 19(13):3550-4. PubMed ID: 19464171
[TBL] [Abstract][Full Text] [Related]
37. Ligand modulated antagonism of PPARgamma by genomic and non-genomic actions of PPARdelta.
Gustafsson MC; Knight D; Palmer CN
PLoS One; 2009 Sep; 4(9):e7046. PubMed ID: 19756148
[TBL] [Abstract][Full Text] [Related]
38. Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma.
Au-Yeung KK; Liu PL; Chan C; Wu WY; Lee SS; Ko JK
Cancer Invest; 2008 Aug; 26(7):708-17. PubMed ID: 18608213
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta.
Knight B; Yeap BB; Yeoh GC; Olynyk JK
Carcinogenesis; 2005 Oct; 26(10):1782-92. PubMed ID: 15917308
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
